Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?
Identifieur interne : 002805 ( PubMed/Checkpoint ); précédent : 002804; suivant : 002806Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?
Auteurs : Tanja Planinsek Rucigaj [Slovénie] ; Nada Kecelj Leskovec ; Vesna Tlaker ZunterSource :
- Radiology and oncology [ 1581-3207 ] ; 2010.
Abstract
Secondary lymphedema following cancer therapy is a frequent, often painful, quality of life disturbing condition, reducing the patients' mobility and predisposing them to complications, e.g. infections and malignancies. The critical aspect of lymphedema therapy is to start as soon as possible to prevent the irreversible tissue damage.
DOI: 10.2478/v10019-010-0047-3
PubMed: 22933923
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:22933923Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?</title><author><name sortKey="Rucigaj, Tanja Planinsek" sort="Rucigaj, Tanja Planinsek" uniqKey="Rucigaj T" first="Tanja Planinsek" last="Rucigaj">Tanja Planinsek Rucigaj</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatovenereology, University Medical Center Ljubljana, Ljubljana, Slovenia.</nlm:affiliation><country xml:lang="fr">Slovénie</country><wicri:regionArea>Department of Dermatovenereology, University Medical Center Ljubljana, Ljubljana</wicri:regionArea><wicri:noRegion>Ljubljana</wicri:noRegion></affiliation></author><author><name sortKey="Leskovec, Nada Kecelj" sort="Leskovec, Nada Kecelj" uniqKey="Leskovec N" first="Nada Kecelj" last="Leskovec">Nada Kecelj Leskovec</name></author><author><name sortKey="Zunter, Vesna Tlaker" sort="Zunter, Vesna Tlaker" uniqKey="Zunter V" first="Vesna Tlaker" last="Zunter">Vesna Tlaker Zunter</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:22933923</idno><idno type="pmid">22933923</idno><idno type="doi">10.2478/v10019-010-0047-3</idno><idno type="wicri:Area/PubMed/Corpus">002834</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002834</idno><idno type="wicri:Area/PubMed/Curation">002834</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002834</idno><idno type="wicri:Area/PubMed/Checkpoint">002834</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002834</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?</title><author><name sortKey="Rucigaj, Tanja Planinsek" sort="Rucigaj, Tanja Planinsek" uniqKey="Rucigaj T" first="Tanja Planinsek" last="Rucigaj">Tanja Planinsek Rucigaj</name><affiliation wicri:level="1"><nlm:affiliation>Department of Dermatovenereology, University Medical Center Ljubljana, Ljubljana, Slovenia.</nlm:affiliation><country xml:lang="fr">Slovénie</country><wicri:regionArea>Department of Dermatovenereology, University Medical Center Ljubljana, Ljubljana</wicri:regionArea><wicri:noRegion>Ljubljana</wicri:noRegion></affiliation></author><author><name sortKey="Leskovec, Nada Kecelj" sort="Leskovec, Nada Kecelj" uniqKey="Leskovec N" first="Nada Kecelj" last="Leskovec">Nada Kecelj Leskovec</name></author><author><name sortKey="Zunter, Vesna Tlaker" sort="Zunter, Vesna Tlaker" uniqKey="Zunter V" first="Vesna Tlaker" last="Zunter">Vesna Tlaker Zunter</name></author></analytic><series><title level="j">Radiology and oncology</title><idno type="eISSN">1581-3207</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Secondary lymphedema following cancer therapy is a frequent, often painful, quality of life disturbing condition, reducing the patients' mobility and predisposing them to complications, e.g. infections and malignancies. The critical aspect of lymphedema therapy is to start as soon as possible to prevent the irreversible tissue damage.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">22933923</PMID><DateCreated><Year>2012</Year><Month>08</Month><Day>30</Day></DateCreated><DateCompleted><Year>2012</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2013</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1581-3207</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Radiology and oncology</Title><ISOAbbreviation>Radiol Oncol</ISOAbbreviation></Journal><ArticleTitle>Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?</ArticleTitle><Pagination><MedlinePgn>244-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2478/v10019-010-0047-3</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Secondary lymphedema following cancer therapy is a frequent, often painful, quality of life disturbing condition, reducing the patients' mobility and predisposing them to complications, e.g. infections and malignancies. The critical aspect of lymphedema therapy is to start as soon as possible to prevent the irreversible tissue damage.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We performed a retrospective study of patients with lymphedema, treated at the Department of Dermatovenereology, University Medical Center Ljubljana, from January 2002 to June 2010. The patients' demographic and medical data were collected, including type of cancer, type and stage of lymphedema, and time to first therapy of lymphedema. The number of referred patients with lymphedema following the therapy of melanoma, breast cancer, and uterine/cervical cancer, was compared to the number of patients expected to experience lymphedema following cancer therapy, calculated from the incidence reported in the literature.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the period of 8.5 years, 543 patients (432 females, 112 males) with lymphedema were treated. The results show that probably many Slovenian patients with secondary lymphedema following cancer therapy remain unrecognized and untreated or undertreated. In the majority of our patients, the management of lymphedema was delayed; on average, the patients first received therapy for lymphedema 3.6 years after the first signs of lymphedema.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To avoid a delay in diagnosis and therapy, and the complications of lymphedema following cancer therapy, the physician should actively look for signs or symptoms of lymphedema during the follow-up period, and promptly manage or refer the patients developing problems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rucigaj</LastName><ForeName>Tanja Planinsek</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Dermatovenereology, University Medical Center Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leskovec</LastName><ForeName>Nada Kecelj</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Zunter</LastName><ForeName>Vesna Tlaker</ForeName><Initials>VT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Slovenia</Country><MedlineTA>Radiol Oncol</MedlineTA><NlmUniqueID>9317213</NlmUniqueID><ISSNLinking>1318-2099</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Strahlenther Onkol. 1998 Oct;174(10):504-9</RefSource><PMID Version="1">9810317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiother Oncol. 1999 May;51(2):161-7</RefSource><PMID Version="1">10435808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 2000 Apr;136(4):511-4</RefSource><PMID Version="1">10768650</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2001 Mar;110(4):288-95</RefSource><PMID Version="1">11239847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Aug 15;92(4 Suppl):980-7</RefSource><PMID Version="1">11519024</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2003 Jun;36(2):84-91</RefSource><PMID Version="1">12926833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2004 Jan;187(1):69-72</RefSource><PMID Version="1">14706589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Cancer. 2004 Jan-Mar;41(1):8-12</RefSource><PMID Version="1">15105573</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2004 Dec;37(4):168-73</RefSource><PMID Version="1">15693529</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>QJM. 2005 May;98(5):343-8</RefSource><PMID Version="1">15820971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann N Y Acad Sci. 2008;1131:147-54</RefSource><PMID Version="1">18519968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>ANZ J Surg. 2008 Nov;78(11):982-6</RefSource><PMID Version="1">18959697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Radiol Oncol. 2010 Mar;44(1):1-12</RefSource><PMID Version="1">22933884</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC3423708</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer therapy, adverse effects</Keyword><Keyword MajorTopicYN="N">lymphedema, secondary lymphedema</Keyword><Keyword MajorTopicYN="N">radiotherapy, adverse effects</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>10</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22933923</ArticleId><ArticleId IdType="doi">10.2478/v10019-010-0047-3</ArticleId><ArticleId IdType="pii">rado-44-04-244</ArticleId><ArticleId IdType="pmc">PMC3423708</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Slovénie</li></country></list><tree><noCountry><name sortKey="Leskovec, Nada Kecelj" sort="Leskovec, Nada Kecelj" uniqKey="Leskovec N" first="Nada Kecelj" last="Leskovec">Nada Kecelj Leskovec</name><name sortKey="Zunter, Vesna Tlaker" sort="Zunter, Vesna Tlaker" uniqKey="Zunter V" first="Vesna Tlaker" last="Zunter">Vesna Tlaker Zunter</name></noCountry><country name="Slovénie"><noRegion><name sortKey="Rucigaj, Tanja Planinsek" sort="Rucigaj, Tanja Planinsek" uniqKey="Rucigaj T" first="Tanja Planinsek" last="Rucigaj">Tanja Planinsek Rucigaj</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002805 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002805 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:22933923
|texte= Lymphedema following cancer therapy in Slovenia: a frequently overlooked condition?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:22933923" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |